Kimberly-Clark Corp (NYSE: KMB) reported Q3 FY23 sales growth of 2% Y/Y to $5.13 billion, missing the analyst consensus estimate of $5.15 billion.

Organic sales increased by 5% driven by a 5% increase in price and favorable product mix and ongoing revenue growth management programs, offset by a 1% decrease in volume.

In North America, organic sales rose 9% in Personal Care, 4% in Consumer Tissue, and 7% in K-C Professional. 

Gross margin expanded 530 bps Y/Y to 35.8%, led by higher net revenue realization, cost savings, and favorable input costs.

Operating income rose ...

Full story available on Benzinga.com